|
CNKSR3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.217200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.77120000000231E-05 |
| Normal-vs-Stage2 |
5.325800E-01 |
| Normal-vs-Stage3 |
5.786400E-01 |
| Normal-vs-Stage4 |
9.111800E-01 |
| Stage1-vs-Stage2 |
4.912300E-02 |
| Stage1-vs-Stage3 |
1.061040E-03 |
| Stage1-vs-Stage4 |
2.015500E-04 |
| Stage2-vs-Stage3 |
8.077200E-01 |
| Stage2-vs-Stage4 |
5.058400E-01 |
| Stage3-vs-Stage4 |
5.568000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.438400E-02 |
| Normal-vs-AfricanAmerican |
2.615600E-02 |
| Normal-vs-Asian |
3.402400E-01 |
| Caucasian-vs-AfricanAmerican |
2.169000E-01 |
| Caucasian-vs-Asian |
4.943400E-01 |
| AfricanAmerican-vs-Asian |
9.474600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.511900E-02 |
| Normal-vs-Female |
4.429600E-04 |
| Male-vs-Female |
1.689630E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.023800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.124800E-03 |
| Normal-vs-Age(61-80Yrs) |
8.486300E-02 |
| Normal-vs-Age(81-100Yrs) |
7.742400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.612200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.964400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.144200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.149620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.740000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.055200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.969620E-02 |
| Normal-vs-Grade 2 |
9.79770000000268E-05 |
| Normal-vs-Grade 3 |
4.448000E-02 |
| Normal-vs-Grade 4 |
1.577360E-01 |
| Grade 1-vs-Grade 2 |
3.707000E-01 |
| Grade 1-vs-Grade 3 |
1.445770E-01 |
| Grade 1-vs-Grade 4 |
1.321070E-03 |
| Grade 2-vs-Grade 3 |
7.198000E-02 |
| Grade 2-vs-Grade 4 |
1.91049999997972E-06 |
| Grade 3-vs-Grade 4 |
2.136300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.5546000042832E-09 |
| Normal-vs-ccB subtype |
1.947420E-01 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.338200E-03 |
| Normal-vs-N1 |
4.043200E-01 |
| N0-vs-N1 |
7.628100E-02 |
|
|
